Fezoulidis 1987.
Study characteristics | |||
Patient sampling |
Country Germany Study design Prospective Setting Hospital Dates of data collection 1984 ‐ 1986 Population (n) 48 Inclusion criteria radical surgery Exclusion criteria No exclusion criteria were defined; results from all 48 participants are included in the study Participants Included (n) 48 |
||
Patient characteristics and setting |
Age range Study does not describe age bands; median age is 64 Smoking status N/R Site of primary tumour Rectum Stage of primary tumour Dukes A 9, Dukes B 16, Dukes C1 19, Dukes C2 4 Perioperative investigations done to ensure no residual disease N/R Chemotherapy/radiotherapy? N/R Recurrences (n) 5 Site of recurrences 5 local rectal recurrences |
||
Index tests |
CEA timing 6 weeks, (then 3‐monthly); main text of the study only mentions that CEA was measured postoperatively; ?Only once; it is not clear if there was a sequence of measurements. Table 4 looks more like a one‐off CEA technique Unknown CEA threshold 2.5 µg/L Definition of positive Unclear Which CEA value (s) used? Probably 4 ‐ 6 weeks postoperatively |
||
Target condition and reference standard(s) |
Follow‐up schedule 4 ‐ 6 weeks postoperatively, then 3‐monthly clinical examination, CT, and CEA Reference standard 4 patients underwent CT guided biopsy but at unknown stage |
||
Flow and timing |
Timing of CEA vs reference standard (days) Unclear |
||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Low | Low | ||
DOMAIN 2: Index Test All CEA thresholds | |||
If a threshold was used, was it pre‐specified? | Yes | ||
Is the same method and instrument used for all CEA measurements? | Unclear | ||
Is there an estimation of reproducibility of the method, for example the % coefficient of variation at specific concentrations? | No | ||
Is there an indication of method accuracy, for example, is there evidence of participation in an external quality assessment and proficiency testing scheme? | No | ||
Unclear | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Low | Low | ||
DOMAIN 4: Flow and Timing | |||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Was the index test repeated prior to the reference standard? | No | ||
Was the the timing between index test(s) and reference standard ascertainable? | Yes | ||
Did all patients receive a reference standard? | Yes | ||
Low |